StockNews.com initiated coverage on shares of Calumet Specialty Products Partners (NASDAQ:CLMT – Free Report) in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the oil and gas company’s stock.
Separately, The Goldman Sachs Group dropped their target price on Calumet Specialty Products Partners from $19.00 to $17.00 and set a buy rating on the stock in a report on Thursday, March 21st.
Check Out Our Latest Stock Report on Calumet Specialty Products Partners
Calumet Specialty Products Partners Stock Up 2.6 %
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) last announced its quarterly earnings results on Friday, February 23rd. The oil and gas company reported ($0.59) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.40). The company had revenue of $976.50 million for the quarter, compared to analysts’ expectations of $856.71 million. During the same period last year, the business posted ($0.21) earnings per share. The company’s revenue for the quarter was down 2.3% compared to the same quarter last year. Research analysts anticipate that Calumet Specialty Products Partners will post -0.52 earnings per share for the current year.
Institutional Trading of Calumet Specialty Products Partners
Large investors have recently modified their holdings of the business. Wasserstein Debt Opportunities Management L.P. purchased a new position in Calumet Specialty Products Partners in the fourth quarter valued at about $119,698,000. Raymond James & Associates boosted its stake in shares of Calumet Specialty Products Partners by 11.0% during the 1st quarter. Raymond James & Associates now owns 504,368 shares of the oil and gas company’s stock valued at $7,495,000 after buying an additional 50,008 shares during the last quarter. Grizzlyrock Capital LLC acquired a new stake in shares of Calumet Specialty Products Partners during the fourth quarter worth approximately $8,909,000. Corient Private Wealth LLC bought a new stake in shares of Calumet Specialty Products Partners in the fourth quarter worth $8,312,000. Finally, Barclays PLC raised its holdings in Calumet Specialty Products Partners by 38.1% in the third quarter. Barclays PLC now owns 200,870 shares of the oil and gas company’s stock valued at $3,837,000 after acquiring an additional 55,370 shares in the last quarter. 34.41% of the stock is currently owned by institutional investors and hedge funds.
Calumet Specialty Products Partners Company Profile
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Performance brands; Montana/Renewables; and Corporate segments.
See Also
- Five stocks we like better than Calumet Specialty Products Partners
- The How And Why of Investing in Oil Stocks
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- What is a Bond Market Holiday? How to Invest and Trade
- Merger or Not, Albertson’s Companies is a Good Buy
- About the Markup Calculator
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.